Categories: HealthcareNews

Reliant Specialty Infusion Partners with Tennr to Scale and Accelerate Patient Access

NEW YORK, April 16, 2025 /PRNewswire/ — Tennr, the intelligent automation platform for healthcare operations, has announced a strategic partnership with Reliant Specialty Infusion as the infusion provider scales aggressively to meet growing patient demand. With Tennr’s advanced automation capabilities, Reliant Specialty Infusion aims to increase the speed of its insurance verification processes and significantly reduce script-to-seat turnaround times across its expanding network of locations.

The rising prevalence of chronic diseases, advancements in biologic therapies, and shifts in payor policies favoring outpatient settings are driving the expansion of infusion services. As infusion providers scale to meet these needs, operational efficiency has become essential to ensuring timely patient access to care.

“As we scale, maintaining speed and efficiency in our operations is critical,” said Kim Foret, CFO at Reliant Specialty Infusion. “Tennr’s automation technology is a game changer because we’re finally able to have efficient scalability without sacrificing the high-quality, timely care we’re known for.”

“Reliant’s growth is a testament to the quality care they provide,” said Trey Holterman, CEO at Tennr. “And Tennr is all about helping providers give fast, high quality care, so we’re excited to be the solution that’ll complement their dedication to expanding access to specialty infusion services.” 

Reliant Specialty Infusion is a leading provider of specialty infusion services, dedicated to delivering patient-centered care. They have 12 locations across Louisiana, Texas and Oklahoma and plan to continue their expansion in the future.

Tennr is a New York City-based healthcare technology company dedicated to eliminating patient delays throughout the U.S. healthcare system. Founded by Stanford AI Lab and Y Combinator alumni, Tennr has raised over $60M from investors including Andreessen Horowitz (a16z) and Lightspeed Venture Partners. The company’s intelligent automation platform accelerates patient throughput, helping healthcare providers deliver more timely and effective care without adding resources.

For more information, please visit https://www.tennr.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/reliant-specialty-infusion-partners-with-tennr-to-scale-and-accelerate-patient-access-302429448.html

SOURCE Tennr

Staff

Recent Posts

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

38 minutes ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

2 hours ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

2 hours ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

2 hours ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

2 hours ago

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as…

2 hours ago